CROI 2013: The beat goes on -- progress in HIV, HCV infections

Volberding, Paul A.
April 2013
Infectious Disease News;Apr2013, Vol. 26 Issue 4, p5
The author reflects on the advances in the prevention and treatment of HIV and hepatitis C virus (HCV) infections which were discussed at the 2013 Conference on Retroviruses and Opportunistic Infections (CROI) in Atlanta, Georgia.


Related Articles

  • Hepatitis C containing an invisible epidemic. D'Epiro, Nancy Walsh // Patient Care;10/15/1998, Vol. 32 Issue 16, p96 

    Looks at the methods used to control and prevent Hepatitis C in the United States. Estimated number of Americans affected with the disease; Improvement to treatment possibilities in this disease; Advice offered to primary care physicians regarding the treatment of the disease; Reference to a...

  • Moving the Agenda Forward: The Prevention and Management of Hepatitis C Virus Infection Among People Who Inject Drugs. Grebely, Jason; Bruggmann, Philip; Backmund, Markus; Dore, Gregory J. // Clinical Infectious Diseases;Aug2013, Vol. 57 Issue Supp 2, pS29 

    An introduction is presented in which the editors discuss various articles within the issue on topics including the prevention of hepatitis C virus (HCV) infection among people who inject drugs (PWID), the enhancement of HCV assessment among PWID, and the management of HCV treatment in PWID.

  • Breakthrough opens new avenues for hep C vaccine.  // Biomedical Market Newsletter;9/26/2011, Vol. 21, p659 

    The article mentions the potential discovery of an effective treatment and vaccine against hepatitis C virus (HCV).

  • Grounds for hope in treating hepatitis C. Giraudon, Isabelle; Hedrich, Dagmar // Drugnet Europe;Oct-Dec2016, Issue 96, p4 

    The article offers information on the report "Hepatitis C among drug users in Europe: epidemiology, treatment and prevention," published on World Hepatitis Day on July 28, 2016, which provides opportunities for the prevention and treatment of the disease.

  • The phantom menace. Rinaldi, Andrea // EMBO Reports;Jan2006, Vol. 7 Issue 1, p14 

    he article provides strategy in preventing hepatitis C. Hepatitis C is the most prevalent liver disease in the world, the most common cause of liver transplantation in developed countries, and the most frequent blood-borne infection. Treating hepatitis C virus infection is not a trivial matter....

  • Ending hepatitis C in the United States: the role of screening. Coffin, Phillip O; Reynolds, Andrew // Hepatic Medicine: Evidence & Research;2014, Vol. 6, p79 

    The US faces at least two distinct epidemics of hepatitis C virus infection (HCV), and due largely to revised screening recommendations and novel therapeutic agents, corresponding opportunities. As only 49%-75% of HCV-infected persons in the US are aware of their infection, any chance of...

  • 42 Medical and Dental Institutions throughout - Pakistan participate in APPNA and Islamic.  // Pulse International;12/31/2012, Vol. 13 Issue 24, p5 

    The article reports that dental and medical institutions of Pakistan had participated in the awareness campaign of Association of Physicians of Pakistani Descent of North America (APPNA) and Islamic Relief USA against Hepatitis C on November 29, 2012. It mentions that several physicians...

  • Gilead golden in HCV for now but many others in the wings. Powers, Marie // BioWorld Insight;2/3/2014, Vol. 22 Issue 5, p1 

    The article reports that Gilead Sciences Inc., biopharmaceutical company had launched Sofosbuvir (brand name Sovaldi) for treatment of Chronic Hepatitis C virus (HCV) infection. Topics discussed include the U.S. Food and Drug Administration approves Gilead Sovaldi for HCV infection, 80 oral HCV...

  • Hepatitis C Virus Infection: From Margin to Center in Rhode Island and Beyond. TAYLOR, LYNN E. // Rhode Island Medical Journal;Jul2014, Vol. 97 Issue 7, p15 

    The article focuses on epidemiology, prevention and treatment of hepatitis C virus infection (HCV) and mentions that July 28 each year is celebrated as the World Hepatitis Day in honor of Nobel Laureate Baruch Samuel Blumberg's birthday. Topics discussed include HCV treatment guidelines issued...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics